Showing results (2171-2180 of 9,884) with videos related to

Sort By:
Pageof 989
Antibiotics (Basel, Switzerland)|February 27, 2026
Examining the Effects: Lack of Impact by Endolysin and Phage Treatment on Rotifer and Larvae MicrobiotaJaime Romero, Carolina Ramírez, Alda Pardo, et al.
Antibiotics (Basel, Switzerland)|February 27, 2026
Ceftazidime-Avibactam in Multidrug-Resistant Klebsiella spp. Infections: Is Monotherapy as Effective as Combination Therapy?Rukiyye Bulut, İbrahim Erayman, Bahar Kandemir, et al.
Antibiotics (Basel, Switzerland)|February 27, 2026
Evaluation of the Efficacy of Anthelmintic Drugs Against Trichinella spiralis LarvaeSoon-Ok Lee, Su In Heo, Hyeon-Woo Nam, et al.
Antibiotics (Basel, Switzerland)|February 27, 2026
Genomic Characterisation of Pyometra-Associated Escherichia coli in a Lombardy Veterinary Clinic: A Nanopore-Based Case SeriesGabriele Meroni, Alessio Soggiu, Davide Sciannimanico, et al.
Antibiotics (Basel, Switzerland)|February 27, 2026
Design, Synthesis, Spectral, Structural Analysis, and Biological Evaluation of Novel Pyrazole Derivatives as Anti-Tumor, Antimicrobial, and Anti-Biofilm AgentsChristina Zalaru, Florea Dumitrascu, Constantin Draghici, et al.
Antibiotics (Basel, Switzerland)|February 27, 2026
Susceptibility Profile and Multiple Antibiotics Resistance of Escherichia coli, Klebsiella spp., and Enterococci from Small-Scale Cattle Farms in TennesseeGoodness Olakanmi, Maureen Nzomo, Bharat Pokharel, et al.
Antibiotics (Basel, Switzerland)|February 27, 2026
Biophysical Features of Outer Membrane Vesicles (OMVs) from Pathogenic Escherichia coli: Methodological Implications for Reproducible OMV CharacterizationGiorgia Barbieri, Linda Maurizi, Maurizio Zini, et al.
Antibiotics (Basel, Switzerland)|February 27, 2026
The Association Between Antibiotic Use and the Incidence of Third-Generation Cephalosporin-Resistance in Escherichia coli Bloodstream Infections: An Ecological StudyAdi Cohen, Elizabeth Temkin, Mitchell J Schwaber, et al.
Antibiotics (Basel, Switzerland)|February 27, 2026
Clinical Relevance of Antimicrobial Susceptibility Testing Methods in Carbapenem-Resistant Acinetobacter baumannii Pneumonia: A Secondary Analysis of a Randomized Controlled TrialChutchawan Ungthammakhun, Vasin Vasikasin, Nadia Cheh-Oh, et al.
Antibiotics (Basel, Switzerland)|February 27, 2026
Bacteriophage-Based Control of Methicillin-Resistant Staphylococcus aureus: Anti-Biofilm Activity, Surface-Active Formulation Compatibility, and Genomic ContextPeechanika Chopjitt, Wanwisa Kanha, Achiraya Sachit, et al.
Pageof 989